These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33268457)

  • 1. Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.
    Valenzi E; Yang H; Sembrat JC; Yang L; Winters S; Nettles R; Kass DJ; Qin S; Wang X; Myerburg MM; Methé B; Fitch A; Alder JK; Benos PV; McVerry BJ; Rojas M; Morris A; Kitsios GD
    Thorax; 2021 Mar; 76(3):239-247. PubMed ID: 33268457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
    O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.
    Takahashi Y; Saito A; Chiba H; Kuronuma K; Ikeda K; Kobayashi T; Ariki S; Takahashi M; Sasaki Y; Takahashi H
    Respir Res; 2018 Feb; 19(1):34. PubMed ID: 29486761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
    Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
    Invernizzi R; Wu BG; Barnett J; Ghai P; Kingston S; Hewitt RJ; Feary J; Li Y; Chua F; Wu Z; Wells AU; George PM; Renzoni EA; Nicholson AG; Rice A; Devaraj A; Segal LN; Byrne AJ; Maher TM; Lloyd CM; Molyneaux PL
    Am J Respir Crit Care Med; 2021 Feb; 203(3):339-347. PubMed ID: 32692582
    [No Abstract]   [Full Text] [Related]  

  • 7. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
    Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
    Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.
    Verleden SE; Tanabe N; McDonough JE; Vasilescu DM; Xu F; Wuyts WA; Piloni D; De Sadeleer L; Willems S; Mai C; Hostens J; Cooper JD; Verbeken EK; Verschakelen J; Galban CJ; Van Raemdonck DE; Colby TV; Decramer M; Verleden GM; Kaminski N; Hackett TL; Vanaudenaerde BM; Hogg JC
    Lancet Respir Med; 2020 Jun; 8(6):573-584. PubMed ID: 32061334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.
    Fastrès A; Felice F; Roels E; Moermans C; Corhay JL; Bureau F; Louis R; Clercx C; Guiot J
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
    Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.
    Tong X; Su F; Xu X; Xu H; Yang T; Xu Q; Dai H; Huang K; Zou L; Zhang W; Pei S; Xiao F; Li Y; Wang C
    Front Cell Infect Microbiol; 2019; 9():149. PubMed ID: 31165050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study.
    Ju C; Lian Q; Chen A; Xu X; Zhang J; Luo Q; Huang D; Chen R; He J
    Clin Exp Rheumatol; 2022 Sep; 40(9):1666-1673. PubMed ID: 34796840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.
    Morell F; Villar A; Montero MÁ; Muñoz X; Colby TV; Pipvath S; Cruz MJ; Raghu G
    Lancet Respir Med; 2013 Nov; 1(9):685-94. PubMed ID: 24429272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations.
    Rabeyrin M; Thivolet F; Ferretti GR; Chalabreysse L; Jankowski A; Cottin V; Pison C; Cordier JF; Lantuejoul S
    Ann Diagn Pathol; 2015 Aug; 19(4):269-76. PubMed ID: 26025258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical management of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
    Molyneaux PL; Willis-Owen SAG; Cox MJ; James P; Cowman S; Loebinger M; Blanchard A; Edwards LM; Stock C; Daccord C; Renzoni EA; Wells AU; Moffatt MF; Cookson WOC; Maher TM
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1640-1650. PubMed ID: 28085486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.